Jaguar Health, Inc. (JAGX) Gross profit 2016–2025
Jaguar Health, Inc. (JAGX) annual gross profit history from SEC filings — each fiscal year as reported.
$7.7MFY2025 · since FY2016: $89,557 → $7.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.7M | -20.5% |
| FY2024 | $9.7M | +26.0% |
| FY2023 | $7.7M | -22.3% |
| FY2022 | $9.9M | +396.4% |
| FY2021 | $2.0M | -67.2% |
| FY2020 | $6.1M | +211.6% |
| FY2019 | $2.0M | +18.7% |
| FY2018 | $1.7M | -52.6% |
| FY2017 | $3.5M | +3786.7% |
| FY2016 | $89,557 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JAGX financial trends
JAGX RevenueJAGX Net incomeJAGX Net marginJAGX Gross marginJAGX Operating incomeJAGX Operating marginJAGX Operating cash flowJAGX Free cash flowJAGX Capital expendituresJAGX Return on equityJAGX Stock buybacksJAGX Dividends paidJAGX Total assetsJAGX Total liabilitiesJAGX Shareholders’ equityJAGX overview →